Halozyme Therapeutics sees strong Q4 2024 growth, driven by ENHANZE platform royalties. Click here to find out why HALO stock ...
Ballard Power Systems sees a 40% backlog boost fueled by bus and rail orders but faces hydrogen adoption delays. Click here ...
Q4 2024 Earnings Call Transcript March 13, 2025 Ballard Power Systems Inc. beats earnings expectations. Reported EPS is ...